Cargando…

Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”

Detalles Bibliográficos
Autor principal: Shazly, Gamal A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572084/
https://www.ncbi.nlm.nih.gov/pubmed/28884127
http://dx.doi.org/10.1155/2017/6761452
_version_ 1783259465279078400
author Shazly, Gamal A.
author_facet Shazly, Gamal A.
author_sort Shazly, Gamal A.
collection PubMed
description
format Online
Article
Text
id pubmed-5572084
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55720842017-09-07 Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment” Shazly, Gamal A. Biomed Res Int Corrigendum Hindawi 2017 2017-08-13 /pmc/articles/PMC5572084/ /pubmed/28884127 http://dx.doi.org/10.1155/2017/6761452 Text en Copyright © 2017 Gamal A. Shazly. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Shazly, Gamal A.
Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title_full Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title_fullStr Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title_full_unstemmed Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title_short Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
title_sort corrigendum to “ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572084/
https://www.ncbi.nlm.nih.gov/pubmed/28884127
http://dx.doi.org/10.1155/2017/6761452
work_keys_str_mv AT shazlygamala corrigendumtociprofloxacincontrolledsolidlipidnanoparticlescharacterizationinvitroreleaseandantibacterialactivityassessment